Featured Research

from universities, journals, and other organizations

NASA signs agreement to develop nasal spray for motion sickness

Date:
October 12, 2012
Source:
NASA
Summary:
NASA's Johnson Space Center in Houston and Epiomed Therapeutics Inc. of Irvine, Calif., have signed an agreement to develop and commercialize a NASA-crafted, fast-acting nasal spray to fight motion sickness. Under the Space Act Agreement, Epiomed will formulate the drug, called intranasal scopolamine, or INSCOP. Astronauts often experience motion sickness in space. As a result, NASA has conducted extensive research into the causes and treatments for the condition.

NASA's Johnson Space Center in Houston and Epiomed Therapeutics Inc. of Irvine, Calif., have signed an agreement to develop and commercialize a NASA-crafted, fast-acting nasal spray to fight motion sickness.

Under the Space Act Agreement, Epiomed will formulate the drug, called intranasal scopolamine, or INSCOP. Astronauts often experience motion sickness in space. As a result, NASA has conducted extensive research into the causes and treatments for the condition. Scopolamine is effective and can be administered as a tablet or injected. With a precise dosage, the NASA spray formulation has been shown to work faster and more reliably than the oral form.

"NASA and Epiomed will work closely together on further development of INSCOP to optimize therapeutic efficiency for both acute and chronic treatment of motion sickness which can be used by NASA, the Department of Defense and world travelers on land, in the air and on the seas," said Lakshmi Putcha, developer of the innovative treatment strategy at Johnson.

A gel formulation of INSCOP was developed and tested under a Space Act Agreement between Johnson and the Naval Aerospace Medical Research Laboratory in Pensacola, Fla. Results from that trial were published in the journal Aviation, Space and Environmental Medicine in April 2010 that suggest INSCOP is a fast-acting and reliable way to prevent and treat motion sickness.

The U.S. Navy is working on an agreement with Epiomed to test the nasal spray. NASA and Epiomed will collaborate on clinical trials related to the Federal Drug Administration requirements. NASA is transferring sponsorship of future clinical trials and FDA approvals to Epiomed, which will supply the product for use by NASA and others.

For more about Johnson's Human Health and Performance Directorate, which developed INSCOP, visit: http://go.nasa.gov/RiKclM


Story Source:

The above story is based on materials provided by NASA. Note: Materials may be edited for content and length.


Cite This Page:

NASA. "NASA signs agreement to develop nasal spray for motion sickness." ScienceDaily. ScienceDaily, 12 October 2012. <www.sciencedaily.com/releases/2012/10/121012152519.htm>.
NASA. (2012, October 12). NASA signs agreement to develop nasal spray for motion sickness. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2012/10/121012152519.htm
NASA. "NASA signs agreement to develop nasal spray for motion sickness." ScienceDaily. www.sciencedaily.com/releases/2012/10/121012152519.htm (accessed July 22, 2014).

Share This




More Space & Time News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Neil Armstrong's Post-Apollo 11 Life

Neil Armstrong's Post-Apollo 11 Life

Newsy (July 19, 2014) Neil Armstrong gained international fame after becoming the first man to walk on the moon in 1969. But what was his life like after the historic trip? Video provided by Newsy
Powered by NewsLook.com
This Week @ NASA, July 18, 2014

This Week @ NASA, July 18, 2014

NASA (July 18, 2014) Apollo 11 yesterday, Next Giant Leap tomorrow, Science instruments for Europa mission, and more... Video provided by NASA
Powered by NewsLook.com
45 Years Later, Buzz Aldrin on Walking on Moon

45 Years Later, Buzz Aldrin on Walking on Moon

AP (July 18, 2014) Forty-five years ago Sunday, Apollo 11's Neil Armstrong and Buzz Aldrin became the first humans to set foot on the moon. Speaking at the Intrepid Sea, Air & Space Museum, Aldrin described what he was thinking right before the historic walk. (July 18) Video provided by AP
Powered by NewsLook.com
Orbital Cargo Ship Reaches International Space Station

Orbital Cargo Ship Reaches International Space Station

AFP (July 16, 2014) Orbital Sciences Corporation's unmanned cargo ship arrived Wednesday at the International Space Station carrying a load of food and equipment for the six-man crew at the research outpost. Duration: 00:33 Video provided by AFP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins